A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer - Sullivan, Ryan J.; Hollebecque, Antoine; Flaherty, Keith T.; Shapiro, Geoffrey I.; Rodon Ahnert, Jordi; Millward, Michael J.; Zhang, Wei; Gao, Ling; Sykes, Amanda; Willard, Melinda D.; Yu, Danni; Schade, Andrew E.; et al. (Molecular cancer therapeutics, 2020)
Keywords: Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms - drug therapy; Phenylurea Compounds - pharmacology; Phenylurea Compounds - therapeutic use; Pyrimidines - pharmacology; Pyrimidines - therapeutic use; Young Adult